Letter: Co-Trimoxazole in Bubonic Plague.

BMJ
doi 10.1136/bmj.4.5884.108-c
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

BMJ

Related search

Human Anti-Plague Monoclonal Antibodies Protect Mice From Yersinia Pestis in a Bubonic Plague Model

PLoS ONE
Multidisciplinary
2010English

Prophylactic Co-Trimoxazole in Biliary Surgery.

BMJ
1979English

Yersinia Pestis Subverts the Dermal Neutrophil Response in a Mouse Model of Bubonic Plague

mBio
VirologyMicrobiology
2013English

Of Medicine, Race, and American Law: The Bubonic Plague Outbreak of 1900

Law and Social Inquiry
LawSocial Sciences
1988English

Adaptive Response of Yersinia Pestis to Extracellular Effectors of Innate Immunity During Bubonic Plague

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Flea-Borne Transmission Model to Evaluate Vaccine Efficacy Against Naturally Acquired Bubonic Plague

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2004English

Author's Response: Co-Trimoxazole Treatment in Idiopathic Pulmonary Fibrosis

Thorax
PulmonaryRespiratory Medicine
2013English

Co-Trimoxazole-Induced Hypoglycaemia in an Immunosuppressed Intensive Care Patient

Journal of the Intensive Care Society
Critical Care NursingCritical CareIntensive Care Medicine
2016English

Humoral and Cellular Immune Correlates of Protection Against Bubonic Plague by a Live Yersinia Pseudotuberculosis Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy